Fall is here, and amidst the changing leaves, pumpkin spice and heartwarming holidays we are excited to celebrate Depression Awareness Month. October is a time for everyone to band together and support the more than 300 million people who live depression each day. Less than 50% of those people will receive a successful depression treatment, for a variety of reasons: inability to ask for help; traditional medications are ineffective; healthcare shortcomings; inaccessibility to ketamine for depression. But if the collective “we” can spread knowledge and ideas about depression treatment, we may be able to help many people change their lives for the better.

Since the early part of the century, ketamine has gained massive traction as a depression treatment. With a success rate of 70%—astronomical when compared to a 40% success rate for traditional antidepressant medications—ketamine infusions are being recommended more and more often by medical professionals. Although ketamine has hallucinogenic properties, it has a much reduced risk of addiction compared to other opioid and antianxiety drugs. Ketamine is not physically addictive, is generally not prescribed as a take-home medication, and is administered in a clinical setting under close supervision. The rapid responses have changed—and saved—many lives. Those whose lives have been forever impacted by ketamine infusions are not shy to talk about their experiences.

Beyond the ketamine success stories, there have been so many developments with ketamine for depression and psychiatric disorders, just in the last year alone. With Depression Awareness Month in mind, here are some of the top ketamine developments of 2018:

1. Janssen Pharmaceutical now waits for FDA approval of a nasal spray called esketamine, an isomer of ketamine. They seek to make the drug available for millions of people, and with successful trials over the last few years, approval looks promising. In more detail, esketamine targets the glutamate-mediated synaptic plasticity for continuous improvement of depressive symptoms.

2. Oral ketamine, used as an add-on to various treatments, is lacking research, but there was a randomized study created to test the possibility of its use. It consisted of 41 people who are already prescribed certain medications. Results were initially very promising.

3. The first guidelines have been released by an expert group of people to help medical professionals identify, characterize and treat depression for menopause. Ketamine could be an effective treatment for any women who experience depression as a result of these hormone changes.

4. Ketamine infusions for suicidal ideation were studied in three subgroups of patients: in one group, the ideations disappeared, and the other groups saw major improvements to their depressive mood. The results of this study indicate that various levels of suicidality can be treated with ketamine infusions.

To learn more, ask us about ketamine infusions today. Our website offers a wealth of resources for learning about ketamine—you owe it to yourself to get the facts, not just from us but from the dozens of scholarly resources and medical organizations that have published about the topic. There is hope for the millions of Americans suffering from depression. Ketamine treatments may save lives—even the life of someone you care about.

Contact Elev8 MD Wellness Center

Contact our Charlotte ketamine clinic and wellness center for more information about ketamine infusions, and other treatments for depression that may support ketamine infusion therapy.